Literature DB >> 12369858

Interferon-alpha/beta-receptor interactions: a complex story unfolding.

Raj Deonarain1, David C M Chan, Leonidas C Platanias, Eleanor N Fish.   

Abstract

The Type I interferons (IFN-alpha/beta) exhibit pleiotropic biological activities. Notably, the different IFN subtypes activate the same cell surface receptor complex to mediate variable responses. Accumulating evidence suggests that distinct differences in critical amino acid residues among the different IFN-alphas and IFN-beta determine the nature of the ligand-receptor interaction and the subsequent responses. This review focuses on IFN-receptor interactions, the key residues involved in this interaction and the potential for targeted modifications of the ligand to enhance bioactivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12369858     DOI: 10.2174/1381612023393288

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  13 in total

1.  Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha.

Authors:  Raj Deonarain; Amit Verma; Andrew C G Porter; Dirk R Gewert; Leonidas C Platanias; Eleanor N Fish
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

2.  A novel nuclear trafficking module regulates the nucleocytoplasmic localization of the rabies virus interferon antagonist, P protein.

Authors:  Sibil Oksayan; Linda Wiltzer; Caitlin L Rowe; Danielle Blondel; David A Jans; Gregory W Moseley
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

3.  Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex.

Authors:  Sabine R Quadt-Akabayov; Jordan H Chill; Rina Levy; Naama Kessler; Jacob Anglister
Journal:  Protein Sci       Date:  2006-09-25       Impact factor: 6.725

4.  Beta interferon controls West Nile virus infection and pathogenesis in mice.

Authors:  Helen M Lazear; Amelia K Pinto; Matthew R Vogt; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

5.  Suppression of interferon (IFN)-inducible genes and IFN-mediated functional responses in BCR-ABL-expressing cells.

Authors:  Efstratios Katsoulidis; Antonella Sassano; Beata Majchrzak-Kita; Nathalie Carayol; Patrick Yoon; Alison Jordan; Brian J Druker; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2008-02-20       Impact factor: 5.157

6.  Two interferons alpha influence each other during their interaction with the extracellular domain of human type interferon receptor subunit 2.

Authors:  Hana Schmeisser; Inna Gorshkova; Patrick H Brown; Peter Kontsek; Peter Schuck; Kathryn C Zoon
Journal:  Biochemistry       Date:  2007-11-21       Impact factor: 3.162

7.  Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors.

Authors:  Giovanni Vitale; Casper H J van Eijck; Peter M van Koetsveld Ing; Joris I Erdmann; Ernst Jan M Speel; Katy van der Wansem Ing; Diana M Mooij; Annamaria Colao; Gaetano Lombardi; Ed Croze; Steven W J Lamberts; Leo J Hofland
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

8.  Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling.

Authors:  Stephan Wilmes; Oliver Beutel; Zhi Li; Véronique Francois-Newton; Christian P Richter; Dennis Janning; Cindy Kroll; Patrizia Hanhart; Katharina Hötte; Changjiang You; Gilles Uzé; Sandra Pellegrini; Jacob Piehler
Journal:  J Cell Biol       Date:  2015-05-25       Impact factor: 10.539

9.  Binding of interferon reduces the force of unfolding for interferon receptor 1.

Authors:  Silvia G Chuartzman; Reinat Nevo; Sharon Waichman; Dalit Shental; Jacob Piehler; Yaakov Levy; Ziv Reich; Ruti Kapon
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

10.  Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.

Authors:  Kelly M Shepardson; Kyle Larson; Rachelle V Morton; Justin R Prigge; Edward E Schmidt; Victor C Huber; Agnieszka Rynda-Apple
Journal:  MBio       Date:  2016-05-03       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.